10.1080/00397919308009793
The research details a new and efficient synthesis method for trans-3,4-dihydroxy-anti-1,2-epoxy-1,2,3,4-tetrahydro-7,12-dimethylbenz(a)anthracene, a highly carcinogenic metabolite of 7,12-dimethylbenz(a)anthracene (DMBA). The purpose of this study is to provide a facile synthesis approach for this compound, which is significant due to its role as the principal active form of DMBA that binds covalently to DNA in vivo, implicated in carcinogenesis. The synthesis involves key intermediates such as 3-hydroxy-7,12-dimethylbenz(a)anthracene, which is derived from 2-bromo-1,4-dimethylnaphthalene through a series of reactions including Grignard reactions, bromination, and cyclization with polyphosphoric acid (PPA).